# INTS (Intensity Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Intensity Therapeutics, Inc. reported $10.29M in total assets and a net loss of $12.04M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/INTS
- Markdown: https://convexityos.com/fundamentals/INTS.md
- SEC CIK: 0001567264
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:07 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001567264&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$12.37M | Operating profit |
| Net Income | FY 2025 | -$12.04M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$3.70 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $8.49M | Total debt: $87K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Research & Development | $6.79M | $10.50M | $4.79M | $5.13M |
| Total Operating Expenses | $11.97M | $16.59M | $8.32M | $7.55M |
| **Operating Income** | -$11.97M | -$16.59M | -$8.32M | -$7.55M |
| Interest Income | $180K | $314K | $324K | $2.0K |
| Interest Expense | -- | $0 | $305K | $82K |
| Income Tax Expense | $0 | $0 | $0 | $0 |
| **Net Income** | -$11.61M | -$16.27M | -$10.54M | -$7.58M |
| Basic EPS | -$8.56 | -$29.24 | -$34.50 | -$55.50 |
| **Diluted EPS** | -$8.56 | -$29.24 | -$34.50 | -$55.50 |
| Basic Shares Outstanding | 1.4M | 556.3K | 344.7K | 136.4K |
| Diluted Shares Outstanding | 1.4M | 556.3K | 344.7K | 136.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.43M | $1.83M | $1.20M | $1.50M | $1.55M | $1.54M | $2.19M | $1.97M |
| Total Operating Expenses | $3.62M | $3.08M | $2.53M | $3.14M | $2.73M | $2.71M | $3.39M | $3.20M |
| **Operating Income** | -$3.62M | -$3.08M | -$2.53M | -$3.14M | -$2.73M | -$2.71M | -$3.39M | -$3.20M |
| Interest Income | $82K | $77K | $94K | $88K | $59K | $17K | $15K | $28K |
| **Net Income** | -$3.54M | -$3.01M | -$2.43M | -$3.05M | -$2.67M | -$2.54M | -$3.35M | -$3.18M |
| Basic EPS | -$1.09 | -$1.11 | -$0.96 | -- | -$1.55 | -$3.36 | -$5.51 | -- |
| **Diluted EPS** | -$1.09 | -$1.11 | -$0.96 | -- | -$1.55 | -$3.36 | -$5.51 | -- |
| Basic Shares Outstanding | 3.3M | 2.7M | 2.5M | -- | 1.7M | 754.7K | 606.9K | -- |
| Diluted Shares Outstanding | 3.3M | 2.7M | 2.5M | -- | 1.7M | 754.7K | 606.9K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.92M | $2.59M | $8.56M | $1.31M |
| **Cash & Short-Term Investments** | $11.90M | $2.60M | $14.80M | $1.31M |
| Other Current Assets | -- | -- | $6.0K | $76K |
| **Total Current Assets** | $12.71M | $3.36M | $15.46M | $1.45M |
| Other Non-Current Assets | $1.30M | $1.30M | $1.68M | $167K |
| **Total Non-Current Assets** | $1.39M | $1.42M | $1.83M | $306K |
| **Total Assets** | $14.10M | $4.78M | $17.30M | $1.76M |
| Accounts Payable | $583K | $1.22M | $3.05M | $603K |
| **Total Current Liabilities** | $2.15M | $1.75M | $3.96M | $6.82M |
| Other Non-Current Liabilities | -- | $0 | $36K | $36K |
| **Total Non-Current Liabilities** | $79K | $110K | $174K | $36K |
| **Total Liabilities** | $2.23M | $1.86M | $4.13M | $6.86M |
| **Total Debt (incl. Leases)** | $110K | $138K | $158K | $143K |
| Common Stock | $0 | $0 | $1.0K | $0 |
| Retained Earnings | -$78.39M | -$66.78M | -$50.52M | -$38.65M |
| **Total Stockholders' Equity** | $11.88M | $2.92M | $13.16M | -$15.10M |
| Total Equity | $11.88M | $2.92M | $13.16M | -$15.10M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.49M | $9.53M | $10.24M | $11.92M | $7.07M | $2.22M | $929K | $2.59M |
| **Cash & Short-Term Investments** | $8.50M | $9.50M | $10.20M | $11.90M | $7.10M | $2.20M | $900K | $2.60M |
| Accounts Receivable, Net | $41K | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $9.50M | $11.23M | $10.91M | $12.71M | $8.19M | $3.04M | $1.65M | $3.36M |
| Other Non-Current Assets | $710K | $210K | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M |
| **Total Non-Current Assets** | $785K | $292K | $1.39M | $1.39M | $1.40M | $1.41M | $1.41M | $1.42M |
| **Total Assets** | $10.29M | $11.52M | $12.29M | $14.10M | $9.59M | $4.44M | $3.06M | $4.78M |
| Accounts Payable | $1.65M | $1.01M | $636K | $583K | $1.68M | $1.19M | $1.59M | $1.22M |
| **Total Current Liabilities** | $2.58M | $2.25M | $2.24M | $2.15M | $2.28M | $2.16M | $2.63M | $1.75M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $53K | $62K | $70K | $79K | $87K | $95K | $102K | $110K |
| **Total Liabilities** | $2.63M | $2.31M | $2.31M | $2.23M | $2.36M | $2.26M | $2.73M | $1.86M |
| **Total Debt (incl. Leases)** | $87K | $95K | $102K | $110K | $118K | $125K | $131K | $138K |
| Common Stock | $0 | $0 | $0 | $0 | $5.0K | $3.0K | $2.0K | $0 |
| Retained Earnings | -$87.37M | -$83.83M | -$80.82M | -$78.39M | -$75.34M | -$72.67M | -$70.13M | -$66.78M |
| **Total Stockholders' Equity** | $7.65M | $9.21M | $9.98M | $11.88M | $7.22M | $2.18M | $334K | $2.92M |
| Total Equity | $7.65M | $9.21M | $9.98M | $11.88M | $7.22M | $2.18M | $334K | $2.92M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$11.61M | -$16.27M | -$10.54M | -$7.58M |
| Stock-Based Compensation | $2.00M | $3.07M | $1.40M | $1.17M |
| **Operating Cash Flow** | -$9.23M | -$15.22M | -$7.21M | -$5.48M |
| Purchases of Investments | $0 | -$3.06M | -$15.05M | $0 |
| **Investing Cash Flow** | $0 | $6.35M | -$6.02M | $0 |
| **Financing Cash Flow** | $18.56M | $2.90M | $20.47M | $2.25M |
| **Net Change in Cash** | $9.33M | -$5.97M | $7.24M | -$3.23M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.54M | -$3.01M | -$2.43M | -$3.05M | -$2.67M | -$2.54M | -$3.35M | -$3.18M |
| Stock-Based Compensation | $517K | $387K | $387K | $450K | $471K | $644K | $435K | $844K |
| **Operating Cash Flow** | -$2.50M | -$2.34M | -$1.83M | -$2.40M | -$2.39M | -$2.46M | -$1.99M | -$2.67M |
| **Investing Cash Flow** | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $345K | -- |
| **Financing Cash Flow** | $1.47M | $1.62M | $150K | $7.25M | $7.24M | $3.74M | $328K | $2.48M |
| **Net Change in Cash** | -$1.03M | -$716K | -$1.68M | $4.85M | $4.85M | $1.29M | -$1.66M | -$192K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -97.7% | -557.5% | -80.1% | -- |
| Return on Assets (ROA) | -82.3% | -340.1% | -60.9% | -431.5% |
| Current Ratio | 5.92x | 1.92x | 3.91x | 0.21x |
| Quick Ratio | 5.55x | 1.48x | 3.74x | 0.19x |
| Debt to Equity | 0.01x | 0.05x | 0.01x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -157.3% | -121.2% | -107.2% | -97.7% | -162.5% | -575.9% | -4494.6% | -557.5% |
| Return on Assets (ROA) | -117.0% | -96.9% | -87.0% | -82.3% | -122.4% | -283.1% | -489.8% | -340.1% |
| Current Ratio | 3.68x | 5.00x | 4.86x | 5.92x | 3.60x | 1.40x | 0.63x | 1.92x |
| Quick Ratio | 3.31x | 4.23x | 4.55x | 5.55x | 3.12x | 1.02x | 0.34x | 1.48x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.06x | 0.39x | 0.05x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
